1. Home
  2. THRM vs CSTL Comparison

THRM vs CSTL Comparison

Compare THRM & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gentherm Inc

THRM

Gentherm Inc

HOLD

Current Price

$28.58

Market Cap

844.7M

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$24.63

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRM
CSTL
Founded
1991
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
844.7M
806.3M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
THRM
CSTL
Price
$28.58
$24.63
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$38.60
$47.17
AVG Volume (30 Days)
187.0K
255.8K
Earning Date
04-23-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.59
N/A
Revenue
$554,979,000.00
$344,229,000.00
Revenue This Year
$4.90
$2.42
Revenue Next Year
$7.19
$12.69
P/E Ratio
$49.75
N/A
Revenue Growth
50.16
3.66
52 Week Low
$23.63
$14.59
52 Week High
$39.48
$44.28

Technical Indicators

Market Signals
Indicator
THRM
CSTL
Relative Strength Index (RSI) 45.39 42.64
Support Level $27.02 $21.77
Resistance Level $29.37 $26.44
Average True Range (ATR) 0.82 1.13
MACD 0.28 0.25
Stochastic Oscillator 55.83 56.85

Price Performance

Historical Comparison
THRM
CSTL

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: